Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia

Abdulaali R. Almutairi; Walaa A. Alshahrani; Ghaida K. Alhathlol; Fatimah Alsheikh; Abdulaziz Alakeel; Majed S. Al Yami; Mohammad Fouda; Omar A. Almohammed; Meshal S. Alhamed; Awatif Hafiz; Hussam Kutbi; Alaa Bagalagel; Aisha Alharbi; Mashael Alaboud; Sarah Aljohani; Waddah Ashram

doi:10.1016/j.jsps.2024.102203

10.1016/j.jsps.2024.102203 391 المشاهدات 3 الاقتباسات

الاقتباسات

391

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Abdulaali, R. A., Walaa, A. A., Ghaida, K. A., Fatimah, A., Abdulaziz, A., Majed, S. A. Y., Mohammad, F., Omar, A. A., Meshal, S. A., Awatif, H., Hussam, K., Alaa, B., Aisha, A., Mashael, A., Sarah, A., Waddah, A. (2024). Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.102203

Rabia Gul; Hamid Bashir; Muhammad Sarfraz; Ahson Jabbar Shaikh; Yousef A. Bin Ja · 2024

استشهاد

395

Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems

Kampanart Huanbutta; Vivek Puri; Ameya Sharma; Inderbir Singh; Pornsak Sriamorns · 2024

استشهاد

391

A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities

Hussain A. Al-Omar; Ali Alshehri; Saleh A. Alqahtani; Hana Alabdulkarim; Ali Alr · 2024

استشهاد

394

Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management …